Laboratory diagnosis of overt type 2 diabetes in the first trimester of pregnancy. Issue 9 (22nd June 2017)

• Record Type: Journal Article
• Authors: Hessler, Karen L.; Dunemn, Kathleen
• Is Part Of: Journal of the American Association of Nurse Practitioners. Volume 29:Issue 9(2017)
• Page Start: 521
• Page End: 526
• Publication Date: 2017-06-22
• Subjects: Diabetes mellitus -- pregnancy -- prenatal care -- diagnosis of diabetes -- screening -- nurse practitioner -- advanced practice nurse; Nurse practitioners -- Periodicals; Nursing -- Periodicals; 610.730692
• DOI: 10.1002/2327-6924.12479
• Languages: English
• ISSNs: 2327-6886

Abstract

Abstract: Objective: The objective of this study was to compare the use of hemoglobin A1C to oral glucose tolerance testing to diagnose overt type 2 diabetes in the first trimester of pregnancy. The study used a nonexperimental descriptive design to compare the use of the hemoglobin A1C test results to oral glucose tolerance test results. Methods: The study used a sample of 45 women at high risk for type 2 diabetes in the first trimester of pregnancy. Participants were consented to draw a hemoglobin A1C with their ordered oral glucose tolerance testing for comparison of the two tests' ability to diagnose overt type 2 diabetes. Results: Hemoglobin A1C tests were highly positively correlated with oral glucose tolerance testing for diagnosis of type 2 diabetes in women in the first trimester of pregnancy. Conclusion: The research provides beginning evidence that the hemoglobin A1C should be considered as a first‐tier diagnostic test for overt type 2 diabetes in the first trimester of pregnancy.